NEWS
undefined

undefined

Community Health Initiative: Jiudian Pharmacy Brings Wellness Services to Local Residents

Community Health Initiative: Jiudian Pharmacy Brings Wellness Services to Local Residents

July 5, 2024 – In an effort to promote health awareness and highlight its high-quality products, Jiudian Pharmacy partnered with the Provincial Construction No.6 Company Community Party-Mass Service Station to host a public welfare event. The activity offered residents free trials of Jiuyue® Anti-inflammatory Analgesic Patches and complimentary blood pressure checks.

07

2025

/

07

Jiudian Pharmaceutical Shines at CPHI Shanghai, Expanding Global Collaboration

Jiudian Pharmaceutical Shines at CPHI Shanghai, Expanding Global Collaboration

From June 24 to 26, the CPHI China exhibition was grandly held at the Shanghai New International Expo Center, drawing widespread attention. Jiudian Pharmaceutical made a remarkable appearance, led by Mr. Fan, Vice General Manager of Jiudian Pharmaceutical and General Manager of Jiudian Hongyang; Ms. Zhu, Operations Director of Jiudian Pharmaceutical; and Ms. Zeng , Director of the International Expansion Department of Jiudian Hongyang. The elite team showcased a diverse product portfolio, highlighting the company’s innovation capabilities and commitment to global development.

01

2025

/

07

Jiudian Pharmaceutical Successfully Passes On-Site Inspection for General Food Production License

Jiudian Pharmaceutical Successfully Passes On-Site Inspection for General Food Production License

On June 27, Jiudian Pharmaceutical successfully passed the on-site inspection conducted by the Hunan Provincial Market Supervision Administration for the expansion of its food production license, covering protein solid beverages and tablet candies. This achievement not only strengthens the company’s production capabilities in specialty dietary foods, medical foods, and health supplements but also marks its entry into the general food production sector, injecting new momentum into its diversified development strategy.

01

2025

/

07

Jiudian Hongyang Conducts Patent Training to Enhance Innovation Protection

Jiudian Hongyang Conducts Patent Training to Enhance Innovation Protection

Recently, to strengthen its core competitiveness and elevate intellectual property (IP) awareness across the organization, Jiudian Hongyang hosted a specialized training session titled "Patent Mining and Infringement Determination." The event, led by Ms. Tang, Deputy department head of the IP Office at Jiudian Pharmaceutical Research Institute, brought together key R&D and technical teams—including members from the Excipients & APIs Research Institute, Synthetic Biology Research Lab, and Technology Department—to systematically advance the company’s IP management capabilities.

25

2025

/

06

New Treatment Option for Hyperlipidemia Patients: JiuDian's Choline Fenofibrate Sustained-release Capsules Approved for Market Launch

New Treatment Option for Hyperlipidemia Patients: JiuDian's Choline Fenofibrate Sustained-release Capsules Approved for Market Launch

Recently, JiuDian Pharmaceutical's Choline Fenofibrate Sustained-release Capsules have received marketing approval from  the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The drug is recognized as passing the consistency evaluation for generic drugs in terms of quality and efficacy. As a newly added Class B drug in the latest National Reimbursement Drug List (NRDL), this medication, with its next-generation sustained-release technology, offers significant clinical advantages such as high bioavailability, no need for hepatic metabolism, and safer combination therapy, providing a superior treatment option for patients with hypertriglyceridemia and mixed dyslipidemia.

24

2025

/

06

Tracing the Footsteps of Revolution, Conquering the Summit of Wugong Mountain

Tracing the Footsteps of Revolution, Conquering the Summit of Wugong Mountain

On June 14th, the R&D team of JiuDian Pharmaceutical organized a unique team-building event titled "Tracing the Footsteps of Revolution, Conquering the Summit of Wugong Mountain." This activity seamlessly blended team cohesion with red culture education and nature exploration, taking participants to Jiangxi’s Pingxiang to visit the Anyuan Railway and Mine Workers’ Movement Memorial and challenge themselves with an ascent of Wugong Mountain.

19

2025

/

06

Jiudian Pharmaceutical’s Dapoxetine Hydrochloride Tablets Approved for PE Indication

Jiudian Pharmaceutical’s Dapoxetine Hydrochloride Tablets Approved for PE Indication

Recently, Jiudian Pharmaceutical’s Dapoxetine Hydrochloride Tablets were approved for marketing by CDE of NMPA and passed the consistency evaluation of generic drugs in quality and efficacy. As the only domestically approved drug for the treatment of premature ejaculation (PE), this product is recommended as a first-line treatment in authoritative domestic and international PE diagnosis and treatment guidelines. Manufactured using Jiudian’s self-produced active pharmaceutical ingredients (APIs), the drug aims to provide effective, convenient, and safe treatment options for PE patients.

08

2025

/

06

Jiudian Hongyang's API Docusate Sodium Approved for Market Launch

Jiudian Hongyang's API Docusate Sodium Approved for Market Launch

We are pleased to announce that Jiudian Hongyang's active pharmaceutical ingredient (API) Docusate Sodium (Y20230000318) has successfully passed the review by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) and has been officially approved with an "A" status.

28

2025

/

05

< 1...789...17 >

Hunan Jiudian

Bldg A1, Wukuang Lugu Science and Technology Industry Park, No.28 Lutian Road, Hi-tech development zone, Changsha, Hunan, China     TEL. 0086-731-88220222     

1

Business license

Powered by：CEglobal   Privacy policy